| Three Months Ended March 31, 2026 | |||||||||||
| In millions except margin | Protein Solutions | Prepared Food and Beverage Solutions | |||||||||
| Segment revenue | $ | 460 | $ | 476 | |||||||
| Segment adjusted EBITDA | $ | 100 | $ | 70 | |||||||
| Segment adjusted EBITDA margin | 21.7% | 14.7% | |||||||||
| Guidance | |||||
| In millions except EPS and margin | FY 2026 | ||||
| Revenue | $3,990 - $4,065 | ||||
| Net income margin | 6.1% - 6.6% | ||||
Adjusted EBITDA margin(1) | 17.0% - 17.5% | ||||
| GAAP diluted EPS | $4.70 - $5.15 | ||||
Adjusted EPS(1) | $8.00 - $8.50 | ||||
| (1) Non-GAAP figure. Please see supplemental schedules for adjustments and reconciliations. | |||||
| JBT MAREL CORPORATION | |||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||||
| (Unaudited and in millions, except per share data) | |||||||||||
| Three Months Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Revenue | $ | 936 | $ | 854 | |||||||
| Cost of sales | 607 | 562 | |||||||||
| Gross profit | 329 | 292 | |||||||||
| Gross profit margin | 35.1% | 34.2% | |||||||||
| Selling, general and administrative expense | 261 | 325 | |||||||||
| Operating income (loss) | 68 | (33) | |||||||||
| Operating income margin | 7.3% | (4.0)% | |||||||||
| Pension expense, other than service cost | — | 147 | |||||||||
| Interest expense, net | 10 | 41 | |||||||||
| Other (income) | (2) | (2) | |||||||||
| Income (loss) before income taxes | 60 | (219) | |||||||||
| Income tax provision (benefit) | 15 | (46) | |||||||||
| Net income (loss) | $ | 45 | $ | (173) | |||||||
| Earnings (loss) per share: | |||||||||||
| Basic | $ | 0.86 | $ | (3.35) | |||||||
| Diluted | $ | 0.86 | $ | (3.35) | |||||||
| Weighted average shares outstanding: | |||||||||||
| Basic | 52.2 | 51.7 | |||||||||
| Diluted | 52.4 | 51.7 | |||||||||
| Other business information from operations: | |||||||||||
| Inbound orders | $ | 1,070 | $ | 916 | |||||||
| Orders backlog | $ | 1,490 | $ | 1,311 | |||||||
| JBT MAREL CORPORATION | |||||||||||
| NON-GAAP FINANCIAL MEASURES | |||||||||||
| RECONCILIATION OF DILUTED EARNINGS PER SHARE TO ADJUSTED DILUTED EARNINGS PER SHARE | |||||||||||
| (Unaudited and in millions, except per share data) | |||||||||||
| Three Months Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Net income (loss) | $ | 45 | $ | (173) | |||||||
| Non-GAAP adjustments | |||||||||||
Restructuring related costs, net (1) | (2) | 11 | |||||||||
M&A related costs (2) | 8 | 74 | |||||||||
| Amortization of bridge financing debt issuance cost | — | 12 | |||||||||
| Acquisition related amortization and depreciation | 45 | 42 | |||||||||
Impact on tax provision from Non-GAAP adjustments (3) | (13) | (31) | |||||||||
| Recognition of non-cash pension plan related settlement costs | — | 147 | |||||||||
| Impact on tax provision from non-cash pension plan related settlement costs | — | (37) | |||||||||
| Discrete tax adjustment from M&A activity | — | 5 | |||||||||
| Adjusted income | $ | 83 | $ | 50 | |||||||
| Net income (loss) | $ | 45 | $ | (173) | |||||||
| Total shares and dilutive securities | 52.4 | 51.7 | |||||||||
| Diluted earnings (loss) per share | $ | 0.86 | $ | (3.35) | |||||||
| Adjusted income | $ | 83 | $ | 50 | |||||||
| Total shares and dilutive securities | 52.4 | 51.7 | |||||||||
| Adjusted diluted earnings per share | $ | 1.58 | $ | 0.97 | |||||||
(1) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business and primarily consist of severance and related costs. | |||||||||||
(2) M&A related costs for the three months ended March 31, 2026, include advisory, strategy and integration related costs for completed M&A transactions. | |||||||||||
(3) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for each period shown. | |||||||||||
| The above table reports adjusted income and adjusted diluted earnings per share, which are non-GAAP financial measures. We use these measures internally to make operating decisions and for the planning and forecasting of future periods, and therefore provide this information to investors because we believe it allows more meaningful period-to-period comparisons of our ongoing operating results, without the fluctuations in the amount of certain costs that do not reflect our underlying operating results. | |||||||||||
| JBT MAREL CORPORATION | |||||||||||
| NON-GAAP FINANCIAL MEASURES | |||||||||||
| RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA | |||||||||||
| (Unaudited and in millions) | |||||||||||
| Three Months Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Net income (loss) | $ | 45 | $ | (173) | |||||||
| Income tax provision (benefit) | 15 | (46) | |||||||||
| Interest expense, net | 10 | 41 | |||||||||
Other financing (income) (1) | (2) | (2) | |||||||||
Pension expense, other than service cost (2) | — | 147 | |||||||||
Restructuring and related costs, net (3) | (2) | 10 | |||||||||
M&A related costs (4) | 8 | 74 | |||||||||
Depreciation and amortization (5) | 68 | 61 | |||||||||
| Adjusted EBITDA | $ | 142 | $ | 112 | |||||||
| Total revenue | $ | 936 | $ | 854 | |||||||
| Net income (loss) margin | 4.8% | (20.3)% | |||||||||
| Adjusted EBITDA margin | 15.2% | 13.1% | |||||||||
| (1) Other financing income represents transaction gains from fair value hedges on our foreign currency denominated debt, which are considered non-operating as they relate to our cost of borrowing on this debt. | |||||||||||
(2) Pension expense, other than service cost, is excluded as it represents all non service-related pension expense, which consists of non-cash interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlement charges. | |||||||||||
(3) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business and primarily consist of severance and related costs. | |||||||||||
(4) M&A related costs for the three months ended March 31, 2026, include advisory, strategy and integration related costs for completed M&A transactions. | |||||||||||
(5) Depreciation and amortization, including the acquisition related amortization and depreciation expense, is excluded to determine EBITDA. | |||||||||||
| The above table reports Adjusted EBITDA and Adjusted EBITDA margin, which are non-GAAP financial measures. We use Adjusted EBITDA and Adjusted EBITDA margin internally to make operating decisions and believe that Adjusted EBITDA is useful to investors as a measure of the Company’s operational performance and a way to evaluate and compare operating performance against peers in the Company's industry. | |||||||||||
| JBT MAREL CORPORATION | |||||||||||||||||
| SEGMENT RESULTS | |||||||||||||||||
| (Unaudited and in millions) | |||||||||||||||||
| Three Months Ended March 31, 2026 | |||||||||||||||||
| (In millions) | Protein Solutions | Prepared Food and Beverage Solutions | Total | ||||||||||||||
| Revenue | $ | 460 | $ | 476 | |||||||||||||
| Less: | |||||||||||||||||
| Cost of sales | 289 | 318 | |||||||||||||||
| Research and development | 11 | 7 | |||||||||||||||
Other segment items (1) | 94 | 112 | |||||||||||||||
| Add: | |||||||||||||||||
| Depreciation and amortization | 34 | 31 | |||||||||||||||
| Segment Adjusted EBITDA | $ | 100 | $ | 70 | $ | 170 | |||||||||||
| Less: | |||||||||||||||||
| Interest expense, net | 10 | ||||||||||||||||
| Other (income) | (2) | ||||||||||||||||
| Restructuring related costs | (2) | ||||||||||||||||
| M&A related costs | 8 | ||||||||||||||||
| Depreciation and amortization | 68 | ||||||||||||||||
| Unallocated amounts: | |||||||||||||||||
Corporate expense (2) | 28 | ||||||||||||||||
| Income before income taxes | $ | 60 | |||||||||||||||
| (1) Other segment items for each reportable segment include operating expenses, which primarily consist of selling, general and administrative expenses and corporate and shared service expenses allocated to each segment based upon benefits received. Other segment items exclude the impact of restructuring, M&A and other one-time related costs as they do not reflect the ongoing operations of the underlying business. | |||||||||||||||||
(2) Corporate expense is primarily comprised of unallocated selling, general and administrative expenses and activity that does not meet the criteria of a reportable segment. Corporate expense excludes the impact of depreciation and amortization, restructuring, M&A and other one-time related and non-operating costs shown separately in the table above. | |||||||||||||||||
| JBT MAREL CORPORATION | |||||||||||||||||
| SEGMENT RESULTS | |||||||||||||||||
| (Unaudited and in millions) | |||||||||||||||||
| Three Months Ended March 31, 2025 | |||||||||||||||||
| (In millions) | Protein Solutions | Prepared Food and Beverage Solutions | Total | ||||||||||||||
| Revenue | $ | 378 | $ | 476 | |||||||||||||
| Less: | |||||||||||||||||
| Cost of sales | 247 | 314 | |||||||||||||||
| Research and development | 20 | 10 | |||||||||||||||
Other segment items (1) | 76 | 101 | |||||||||||||||
| Add: | |||||||||||||||||
| Depreciation and amortization | 28 | 27 | |||||||||||||||
| Segment Adjusted EBITDA | $ | 63 | $ | 78 | $ | 141 | |||||||||||
| Less: | |||||||||||||||||
| Interest expense, net | 41 | ||||||||||||||||
| Other (income) | (2) | ||||||||||||||||
| Pension expense, other than service cost | 147 | ||||||||||||||||
| Restructuring related costs | 11 | ||||||||||||||||
| M&A related costs | 74 | ||||||||||||||||
| Depreciation and amortization | 61 | ||||||||||||||||
| Unallocated amounts: | |||||||||||||||||
Corporate expense (2) | 28 | ||||||||||||||||
| Loss before income taxes | $ | (219) | |||||||||||||||
| (1) Other segment items for each reportable segment include operating expenses, which primarily consist of selling, general and administrative expenses and corporate and shared service expenses allocated to each segment based upon benefits received. Other segment items exclude the impact of restructuring, M&A and other one-time related costs as they do not reflect the ongoing operations of the underlying business. | |||||||||||||||||
(2) Corporate expense is primarily comprised of unallocated selling, general and administrative expenses and activity that does not meet the criteria of a reportable segment. Corporate expense excludes the impact of depreciation and amortization, restructuring, M&A and other one-time related and non-operating costs shown separately in the table above. | |||||||||||||||||
| JBT MAREL CORPORATION | |||||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||||
| (Unaudited and in millions) | |||||||||||
| March 31, 2026 | December 31, 2025 | ||||||||||
| Assets | |||||||||||
| Cash and cash equivalents | $ | 211 | $ | 168 | |||||||
| Restricted cash | 19 | 19 | |||||||||
| Trade receivables, net of allowances | 438 | 443 | |||||||||
| Contract assets | 142 | 119 | |||||||||
| Inventories | 667 | 644 | |||||||||
| Other current assets | 198 | 190 | |||||||||
| Total current assets | 1,675 | 1,583 | |||||||||
| Property, plant and equipment, net | 779 | 793 | |||||||||
| Goodwill | 3,393 | 3,428 | |||||||||
| Intangible assets, net | 2,052 | 2,122 | |||||||||
| Other assets | 264 | 265 | |||||||||
| Total Assets | $ | 8,163 | $ | 8,191 | |||||||
| Liabilities and Stockholders' Equity | |||||||||||
| Short-term debt | $ | 411 | $ | 412 | |||||||
| Accounts payable, trade and other | 294 | 262 | |||||||||
| Advance and progress payments | 561 | 518 | |||||||||
| Accrued payroll | 154 | 170 | |||||||||
| Other current liabilities | 237 | 260 | |||||||||
| Total current liabilities | 1,657 | 1,622 | |||||||||
| Long-term debt, less current portion | 1,432 | 1,470 | |||||||||
| Deferred tax liabilities | 379 | 383 | |||||||||
| Other liabilities | 212 | 252 | |||||||||
| Common stock and additional paid-in capital | 2,716 | 2,718 | |||||||||
| Retained earnings | 1,505 | 1,465 | |||||||||
| Accumulated other comprehensive income | 262 | 281 | |||||||||
| Total stockholders' equity | 4,483 | 4,464 | |||||||||
| Total liabilities and stockholders' equity | $ | 8,163 | $ | 8,191 | |||||||
| JBT MAREL CORPORATION | |||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||
| (Unaudited and in millions) | |||||||||||
| Three Months Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income (loss) | $ | 45 | $ | (173) | |||||||
| Adjustments to reconcile income (loss) to cash provided by operating activities: | |||||||||||
| Depreciation and amortization | 68 | 61 | |||||||||
| Stock-based compensation | 7 | 5 | |||||||||
| Other, net | 4 | 174 | |||||||||
| Changes in operating assets and liabilities | |||||||||||
| Trade accounts receivable, net | (21) | 18 | |||||||||
| Inventories | (27) | (13) | |||||||||
| Accounts payable, trade and other | 38 | 21 | |||||||||
| Advance and progress payments | 50 | 32 | |||||||||
| Other assets and liabilities, net | (45) | (91) | |||||||||
| Cash provided by operating activities | 119 | 34 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Acquisitions, net of cash acquired | — | (1,746) | |||||||||
| Capital expenditures | (26) | (20) | |||||||||
| Proceeds from disposal of assets | 7 | 1 | |||||||||
| Other | — | (1) | |||||||||
| Cash required by investing activities | (19) | (1,766) | |||||||||
| Cash flows from financing activities | |||||||||||
| Net repayments of domestic credit facilities, net of debt issuance costs | (38) | (195) | |||||||||
| Net (repayments of) proceeds from Term loan B, net of debt issuance costs | (2) | 898 | |||||||||
| Settlement of deal contingent hedge | — | (43) | |||||||||
| Dividends | (5) | (5) | |||||||||
| Other, net | (9) | (34) | |||||||||
| Cash (required) provided by financing activities | (54) | 621 | |||||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | 46 | (1,111) | |||||||||
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | (3) | 2 | |||||||||
| Net (decrease) increase in cash and cash equivalents | $ | 43 | $ | (1,109) | |||||||
| Cash and cash equivalents from operations, beginning of period | 187 | 1,228 | |||||||||
| Add: Net (decrease) increase in cash and cash equivalents | 43 | (1,109) | |||||||||
| Cash, cash equivalents and restricted cash from operations, end of period | $ | 230 | $ | 119 | |||||||
| JBT MAREL CORPORATION | |||||||||||
| NON-GAAP FINANCIAL MEASURES | |||||||||||
| FREE CASH FLOW | |||||||||||
| (Unaudited and in millions) | |||||||||||
| Three Months Ended March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| Cash provided by operating activities | $ | 119 | $ | 34 | |||||||
| Less: capital expenditures | 26 | 20 | |||||||||
| Plus: proceeds from disposal of assets | 7 | 1 | |||||||||
| Plus: pension contributions | — | 3 | |||||||||
| Free cash flow (FCF) | $ | 100 | $ | 18 | |||||||
| The above table reports free cash flow, which is a non-GAAP financial measure. We use free cash flow internally as a key indicator of our liquidity and ability to service debt, invest in business combinations, and return money to shareholders and believe this information is useful to investors because it provides an understanding of the cash available to fund these initiatives. | |||||||||||
| JBT MAREL CORPORATION | |||||||||||||||||||||||||||||
| NET DEBT CALCULATION | |||||||||||||||||||||||||||||
| (Unaudited and in millions) | |||||||||||||||||||||||||||||
| As of Quarter Ended | Change From | ||||||||||||||||||||||||||||
| Q1 2026 | Q4 2025 | Q1 2025 | Prior Year-End | Prior Year | |||||||||||||||||||||||||
| Total debt | $ | 1,843 | $ | 1,882 | $ | 1,988 | $ | (39) | $ | (145) | |||||||||||||||||||
| Less: cash and marketable securities | 211 | 168 | 101 | 43 | 110 | ||||||||||||||||||||||||
| Net debt | $ | 1,632 | $ | 1,714 | $ | 1,887 | $ | (82) | $ | (255) | |||||||||||||||||||
| JBT MAREL CORPORATION | |||||
| BANK TOTAL NET LEVERAGE RATIO CALCULATION | |||||
| (Unaudited and in millions) | |||||
| Q1 2026 | |||||
| Total debt | $ | 1,843 | |||
| Less: cash and marketable securities | 211 | ||||
| Net debt | 1,632 | ||||
| Other items considered debt under the credit agreement | 47 | ||||
Consolidated total indebtedness(1) | $ | 1,679 | |||
| Trailing twelve months adjusted EBITDA | 630 | ||||
| Other adjustments net to earnings under the credit agreement | 53 | ||||
Consolidated EBITDA(1) | $ | 683 | |||
| Bank total net leverage ratio (Consolidated total indebtedness / Consolidated EBITDA) | 2.5 | ||||
| Total net debt to trailing twelve months adjusted EBITDA | 2.6 | ||||
| (1) As defined in the credit agreement. | |||||
| JBT MAREL CORPORATION | |||||
| NON-GAAP FINANCIAL MEASURES | |||||
| RECONCILIATION OF DILUTED EARNINGS PER SHARE | |||||
| TO ADJUSTED DILUTED EARNINGS PER SHARE GUIDANCE | |||||
| (Unaudited and in cents) | |||||
| Guidance | |||||
| Full Year 2026 | |||||
| Diluted earnings per share | $4.70 - $5.15 | ||||
| Non-GAAP adjustments: | |||||
Restructuring related costs(1) | ~ 0.57 | ||||
M&A related costs(2) | ~ 0.38 | ||||
Acquisition related amortization and depreciation(3) | ~ 3.40 | ||||
Impact on tax provision from Non-GAAP adjustments(4) | ~ (1.02) | ||||
| Adjusted diluted earnings per share | $8.00 - $8.50 | ||||
(1) Restructuring related costs are estimated to be approximately $30 million for the full year 2026. The amount has been divided by our estimate of 52.4 million total shares and dilutive securities to derive earnings per share. | |||||
(2) M&A related costs are estimated to be approximately $20 million for the full year 2026. The amount has been divided by our estimate of 52.4 million total shares and dilutive securities to derive earnings per share. | |||||
(3) Acquisition related amortization and depreciation is expected to be approximately $178 million for the full year 2026. The amount has been divided by our estimate of 52.4 million total shares and dilutive securities to derive earnings per share. | |||||
(4) Impact on tax provision for 2026 tax provision on non-GAAP adjustments was calculated using a tax rate of approximately 23-24% based on a estimate of the tax rate of the country in which the non-GAAP adjustments are originating. | |||||
| JBT MAREL CORPORATION | |||||
| NON-GAAP FINANCIAL MEASURES | |||||
| RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA GUIDANCE | |||||
| (Unaudited and in millions) | |||||
| Guidance | |||||
| Full Year 2026 | |||||
| Net Income | $245 - $270 | ||||
| Income tax provision | 75 - 83 | ||||
| Interest expense, net | ~50 | ||||
Other financing income (1) | ~ (10) | ||||
Restructuring related costs (2) | ~ 30 | ||||
M&A related costs (3) | ~ 20 | ||||
| Depreciation and amortization | ~ 268 | ||||
| Adjusted EBITDA | $675 - $710 | ||||
| Revenue | $3,990 - $4,065 | ||||
| Net income margin | 6.1% - 6.6% | ||||
| Adjusted EBITDA margin | 17.0% - 17.5% | ||||
| (1) Other financing income is estimated to be approximately $10 million for the full year 2026. | |||||
| (2) Restructuring related costs are estimated to be approximately $30 million for the full year 2026. The amount has been divided by our estimate of 52.4 million total shares and dilutive securities to derive earnings per share. | |||||
| (3) M&A related costs are estimated to be approximately $20 million for the full year 2026. The amount has been divided by our estimate of 52.4 million total shares and dilutive securities to derive earnings per share. | |||||